Diabetes Mellitus Diabetes Mellitus
Conditions
Interventions
None listed
Sponsors
Noto Hiroshi
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) Group with diabetes mellitus 1. Male outpatients with Type 2 diabetes mellitus 2. Patients who can give voluntary written consent to participate in the present study. 2) Control group (Group without diabetes mellitus) 1. adult male 2. Persons who can give voluntary written consent to participate in the present study.
Exclusion criteria
Exclusion criteria: 1) Group with diabetes mellitus 1. Patients who have/had diseases which may cause peripheral neuropathy. 2. Patients who have /had diseases which may cause xerosis excluding due to physiological and environmental factors. 3. Patients with skin diseases excluding xerosis at the measurement sites 4. Patients with diabetic foot gangrene or foot ulcer. 5. Patients who are taking drugs for neuropathic pain. 6. Patients with mental disease 7. Patients who are being treated with peripheral vasodilation drugs. 8. Patients who routinely use emollient/moisturizer at the measurement sites. 9. Patients who are considered to be unsuitable for the study by the investigator. 2) Control group (Group without diabetes mellitus) 1. Persons who have/had diseases which may cause peripheral neuropathy. 2. Persons who have /had diseases which may cause xerosis. 3. Persons with skin diseases excluding xerosis at the measurement sites 4. Persons who are taking drugs for more than 28 days. 5. Persons who routinely use emollient/moisturizer at the measurement sites. 6. Persons who are considered to be unsuitable for the study by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Trans epidermal water loss, stratum corneum hydration, overall dry skin score, pruritus NRS, blood flow, capillary formation, current perception threshold, adverse event | — |
Contacts
Public ContactHiroshi Noto
St. Luke's International Hospital
Outcome results
None listed